EP Patent

EP3212621A4 — Novel regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

Assigned to 60 Degrees Pharmaceuticals Inc · Expires 2018-05-23 · 8y expired

What this patent protects

Patent listed against tafenoquine-succinate.

Drugs covered by this patent

tafenoquine-succinate (TAFENOQUINE SUCCINATE)

Patent Metadata

Patent number: EP3212621A4
Jurisdiction: EP
Classification: —
Expires: 2018-05-23
Drug substance claim: No
Drug product claim: No
Assignee: 60 Degrees Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.